Ritonavir Completed Phase 1 Trials for Insulin Resistance Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02203461Changes in Insulin Resistance in Healthy Volunteers on STRIBILDĀ® Medication